Miranda Rosenberg

Miranda Rosenberg practices at New Hyde Park Endoscopy in Lake Success, New York.

Miranda Rosenberg's NPI, 1437685385, was assigned on May 11, 2017. Miranda Rosenberg graduated from Perelman School of Medicine - Philadelphia in 2017. Miranda Rosenberg holds Florida license ME150253.

Miranda Rosenberg's primary practice is New Hyde Park Endoscopy, at 1991 Marcus Avenue, Lake Success, NY 11042. The practice phone is (317) 796-7565.

Miranda Rosenberg's primary practice is New Hyde Park Endoscopy in Lake Success, New York. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Miranda Rosenberg to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Miranda Rosenberg practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Miranda Rosenberg's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Miranda Rosenberg is board certified in dermatology by the American Board of Dermatology. Dmand AI has Miranda Rosenberg's licenses on file in 3 states: Florida, New York and Pennsylvania.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives and itchy rashes among the conditions Miranda Rosenberg treats.

CMS data shows 3,981 Medicare services from Miranda Rosenberg across 25 procedure codes in 2024, for 625 Medicare patients. Medicare paid $222,798 for them. Every service was in an office.

CMS counts 625 Medicare patients who saw Miranda Rosenberg in 2024. The largest group is 75 to 84, with 269 patients. 75% of them have high cholesterol, and 68% have high blood pressure. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Miranda Rosenberg's median patient age at 65, with 54% women.

In 2024, Miranda Rosenberg wrote 617 Medicare Part D claims for 281 patients. 93% of them were for generic drugs. CMS names the drug for 466 of them, across 14 drugs with 11 or more claims each, at $7,698 in total drug cost. In 2023, CMS named 535 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Miranda Rosenberg for performance year 2024, reported as part of a group. CMS counts 105 procedures of removal of skin lesions by Miranda Rosenberg, more than 75% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Miranda Rosenberg, published from 2018 to 2024. Miranda Rosenberg has published most often in Nature. Miranda Rosenberg's most frequent co-authors are Vijay Joshi, MBCHB, FRCS, Michael B. Gerhardt, MD and Wei Ching Lee, MD.

CMS Open Payments shows 184 general payments to Miranda Rosenberg from 33 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 92% of the total. Abbvie Inc. paid the most, $939.

Miranda Rosenberg graduated from Perelman School of Medicine - Philadelphia in 2017.

Miranda Rosenberg is in network with 6 carriers, including Aetna, Cigna and Humana. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.